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Abstract 
Post translational modifications (PTMs) including trimethyllysine (Kme3) on histone tails 
serve as epigenetic markers that influence gene expression, and antibodies have been crucial tools 
for detecting PTMs on histone tails. However, antibody recognition is sensitive to local sequences 
as well as neighboring PTMs, and antibodies cannot efficiently distinguish among specific 
methylation states of lysine. Proteins bind PTMs on histone tails, their inherent specificity is a 
candidate mechanism for detecting PTMs. Here, we took advantage of the selectivity of native 
reader proteins and created high affinity variants that recognize Kme3 at position 9 on histone 3 
(H3K9me3). Previously, single point mutations of the Heterochromatin protein 1 (HP1) from 
Drosophila melanogaster chromodomain confer 2-fold higher affinity binding on native Kme3 
substrates. We hypothesized that combinations of mutations (A25T, K46A, E52D, D62F) would 
have additive effects on the affinity of HP1 with Kme3. A triple mutant (K46A/E52D/D62F) 
exhibited increased binding by ~ 20-fold with respect to wild-type. The triple mutant HP1 protein 
also showed increased selectivity to H3K9me3 than the wild-type protein. This mutant will provide 
a new tool with higher specificity to trimethyllysine, which will complement current antibody-
based approaches for detecting and distinguishing PTMs in standard biochemical assays. Since 
many diseases are associated with dysregulation of gene expression due to abnormal PTMs, such 




Epigenetics is defined as any process that alters gene activity without changing the DNA 
sequence11. It is an increasingly important field for the study of diseases. Dysregulation of 
transcriptional factors and the epigenome lead to aberrant gene expression programs in cancer7. A 
major feature of epigenetic regulation is the condensation of DNA into chromosomes in 
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eukaryotes. Chromatin can either be loosely packed and allow active gene transcription 
(euchromatin) or it can be more tightly packed and have less accessible genes (heterochromatin)4. 
Epigenetics is in part determined by the histone code, which is the idea that transcription 
of genetic information is regulated by epigenetic modifications, specifically post-translational 
modifications (PTMs) to histones5. Histones form an octamer complex that contain two copies of 
each histone protein (H2A, H2B, H3, H4) and have ~147 base pairs of DNA wrapped around them. 
Once DNA is wrapped around them, they form nucleosomes and further condense into 
chromatin17. DNA-interacting histone proteins are conserved across eukaryotic species and are 
subject to frequent PTMs. Specifically, these PTMs primarily occur on the unstructured N-terminal 
tail of the histone proteins5. 
The PTMs on the histone tails are able to be recognized by effector proteins. These effector 
proteins regulate gene expression17. These epigenetic regulators can be divided into erasers, 
writers, or readers of PTMs. Erasers are enzymes that remove PTMs; writers are enzymes that 
install PTMs on histone tails; and readers are proteins that have specific binding domains (reader 
domains) that bind to particular modifications, interpret modifications, and recruit other proteins 
to then change chromatin structure7. 
The current methods for detecting PTMs include antibodies. Antibodies are reasonably 
precise at recognizing their target modification and are used to detect certain histone modifications 
in western blots and chromatin immunoprecipitation13. Antibodies, however, have difficulties 
distinguishing between methylation states of lysine, which are thought to mediate different 
biological outcomes. Furthermore, antibodies are influenced by neighboring sequences, cannot 
distinguish between combinatorial PTMs, have cross-reactivity to unexpected antigens, and are 
expensive5,13. These problems associated with antibodies can lead to misinformed conclusions 
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regarding the location and function of the desired histone PTMs.  Despite these limitations, 
antibodies have been vital tools for detecting PTMs. Although many protein domains that bind 
selectively to particular PTMs have been identified, the combinatorial readout of neighboring 
modifications is complex and an ongoing area of research. 
 A solution to the limitations of antibodies are reader proteins engineered to be affinity 
reagents. Reader proteins typically bind to histone tails in the mid-to-low-micromolar range, 
whereas antibodies bind in the nanomolar range.  Reader proteins with strong binding affinities 
for the histone tail that selectively recognize PTMs have the potential to be a cheaper option for 
academic research and more reliable in terms of detection than antibodies10. Our research thus far 
has centered around engineering a methylated lysine reader protein, the chromodomain of 
heterochromatin protein 1 (HP1) from Drosophila melanogaster, to possess a higher affinity in the 
nanomolar range than the native reader protein. The chromodomain of dHP1 from Drosophila 
melanogaster selectively binds trimethyllysine (Kme3) at position 9 on histone H3. 
There are two modes of interactions for binding of H3K9me3 by the HP1 chromodomain8. 
The first is through cation-π interaction between trimethyllysine 9 of the H3 histone tail and the 
three-member aromatic cage of the chromodomain2,3,15. The second is the formation of anti-
parallel three-stranded β-sheet (Thr6 through Ser10) with H3 histone tail as the central strand and 
two β-strands of the chromodomain reader protein as the edge strands2,3,15 (Figure 1).  
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Figure 1. Left: Anti-parallel three-stranded β-sheet, Right: Mutations A25T, K46A, E52D, D62F in HP1 
chromodomain, H3 Kme3 (Yellow), A25T (Green), K46A (Green), E52D (Green), D62F (Green) correspond 
to the orange arrows of the picture on the right (HP1 23-27 and HP1 60-63).  
 
Four rational point mutations were previously discovered in or near the chromodomain of 
HP1: histone interface (A25T, K46A, E52D, D62F)3. These point mutations increase the binding 
by ~2, 10, 2, 3 fold, respectively, compared to the wild type reader protein2,3. These mutations 
were originally chosen for mutagenesis because positions 25 and 62 are both involved in the β-
sheet cross strand interactions with T6 on the histone tail. A25T creates a cross-strand Thr-Thr 
interaction, which has been shown to be favorable. D62F creates a Thr-Phe cross strand interaction, 
which may be favorable because of Phe’s greater β-sheet propensity18,19. K46A is located near the 
aromatic cage and may result in better positioning of amino acids involved in cation-π interactions, 
thereby tightening binding. Finally, E52D was included because it provides a 2-fold tighter binding 
and selectivity for Kme3 over Kme22,3,16.   
We hypothesize that there will be an additive effect made possible via combinations of 







improve from 15 µM to ~80 nM. These point mutations, along with mutations in the aromatic cage 
would improve the binding affinity to the nanomolar range necessary for biochemical assays 
(Hypothesis 1). Secondly, we aim to focus on the application of the Super Binder reader proteins 
in biochemical assays. We hypothesize that HP1 variants will improve affinity for Kme3-modified 
histones and will complement the current epigenetic toolbox for use in standard assays (Hypothesis 
2). If a super binder is able to be engineered, the reader protein could assist current antibody 
approaches for detecting PTMs with increased specificity and less variability.  Our data suggests 
that the A25T mutation does not actually improve binding, therefore the quadruple mutant does 
not have the greatest increase in binding affinity. Furthermore, combinatorial mutations of one 
triple mutant (K46A/E52D/D62F) increased the binding affinity of the reader protein to the 
nanomolar scale. For our second hypothesis, the triple mutant protein (K46A/E52D/D62F) was 
used in peptide-pulldown assays and microarrays to test the binding affinity in solution and the 
specificity to trimethyllysine of the mutant. For the peptide-pulldown assays, the triple mutant was 
used at a 10-fold lower concentration than the wild-type. It was found that the triple mutant bound 
with high specificity and tighter binding to H3K9me3 when compared to the wild-type. The 
microarrays found the triple mutant had a higher binding affinity for H3K9me and had higher 
specificity for H3K9me.   
Methods: Hypothesis 1 
Synthesis of HP1 histone tail binding interface 
The combinatorial mutagenesis of the chromodomain of HP1: histone tail binding interface 
was introduced onto a pET11a plasmid containing the Drosophila HP1 chromodomain. The 
mutants were generated using a combination of QuikChange PCR (whole plasmid PCR), gradient 
QuikChange PCR with annealing temperatures ranging from 65°C-85°C, and overlap PCR.  The 
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primers used for QuikChange PCR and gradient PCR are listed in Table 1 and the Primers for 
Overlap PCR are listed in Table 2.  After performing gel electrophoresis on the PCR products with 
bands around ~6 kb, a Dpn-1 digest was performed to remove the template plasmid.  Another gel 
electrophoresis was run to ensure the plasmid from PCR was still present. The plasmid was then 
transformed into BL21-DE3 Escherichia coli cells by electroporation, and successful 
transformants were selected for by resistance to ampicillin. DNA isolated from single colonies was 
sent for Sanger sequencing (Genewiz) to confirm the presence of desired mutations. To express 
and isolate the HP1 mutants, the cells were grown to an A600 value of 0.5-0.7 in Lysogeny Broth 
(LB) medium containing ampicillin. Protein expression was induced with isopropyl β-D-1-
thiogalactopyranoside (IPTG) and grown overnight at 18 °C. The cell cultures were pelleted by 
centrifugation, then lysed by chemical lysis and sonication. The protein was purified using Ni-
affinity chromatography and concentrated using Millipore Amicon filters.  
H3 Histone Tail Synthesis 
 H3 histone tail peptides were synthesized by Fmoc solid-phase peptide synthesis using a 
Tetras synthesizer. The sequence reflects residues 1-15 of H3 and includes a tyrosine at the C-
terminus for concentration determination. The peptide was purified by reverse-phase 
chromatography. 
Isothermal titration calorimetry 
 
Isothermal titration calorimetry (ITC) measures binding affinity by titrating the H3 histone 
tail peptide into the protein sample and measuring the change in heat as a result of binding. Peptide 
and protein were dissolved in 50 mM sodium phosphate, 2 mM TCEP, pH 7.4 to a concentration 
of ~1 mM and ~100 uM, respectively. Binding affinity was calculated by the MicroCal Analysis 
software, in which Kd is determined from the slope of the binding isotherm.  
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Circular Dichorism Analysis 
Circular Dichorism Analysis (CD) measurements were performed on an Aviv 62DS 
Circular Dichorism Spectrometer. CD data was obtained using 25 uM protein in 10 mM Na2HPO4, 
pH 7.4, 2 mM DTT at 25°C. Thermal denaturation experiments were performed using the same 
buffer and concentrations and measurements were taken between 3 and 93°C2,3. A thermal melting 
experiment was also completed to determine the stability of the mutant proteins. This was done 
under the same conditions as CD. Equation 1 was used to graph the thermal melting curve. 
Equation 1 
𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑓𝑜𝑙𝑑𝑒𝑑 = (𝜃 − 𝜃𝐷)/(𝜃𝐹 − 𝜃𝐷) 
Θ is the observed MRE, ΘD is the MRE for the fully denatured protein, and ΘF is MRE for the fully folded protein. 
 
Methods: Hypothesis 2 
Glutathione S-Transferase Tags 
The wild type and mutant HP1 proteins were tagged with Glutathione S-Transferase (GST) 
as a handle for secondary antibody recognition. A PCR was performed to install BamHI and XmaI 
cut sites on the 5’ and 3’ end. The pET11a plasmid was then digested with BamHI and with XmaI 
to remove the HP1 gene. A new plasmid, pGEX-6P-2, contains the GST gene and was digested 
with BamHI on the 5’ end and with XmaI on the 3’ end. HP1 was then ligated into pGEX-6P-2 
using T4 DNA ligase. The ligation was then transformed into BL21-DE3, and successful 
transformants were sequenced for accuracy. The GST fusions were expressed in LB and purified 




In-solution Peptide Pulldown Assays 
The peptide pulldowns were done in collaboration with Brian Strahl’s Group and 
performed by Dr. Chris Petell. The GST tagged proteins (WT and mutant) were incubated with 
biotinylated histone peptide for 1 hour at 4 °C in peptide binding buffer (50 mM Tris pH 8.0, 300 
mM NaCl, 0.1% NP-40). The protein-peptide mixture was loaded onto a column containing 
streptavidin-coated magnetic beads. The mutant protein has a 10-fold less concentration than the 
wild-type protein. The column was washed with 50 mM of salt NaCl Phosphate buffer. The protein 
was eluted with either 300 mM or 500 mM NaCl Phosphate buffer. The fractions from wash and 
elutions were run on an SDS page gel and transferred to a PVDF membrane. The membrane was 
then incubated with anti-GST antibodies, washed, then incubated with an anti-rabbit HRP antibody 
for visualization. Enrichment is quantified based on image density analysis. 
Peptide Microarrays 
The peptide microarrays were in collaboration with Brian Strahl’s Group and performed 
by Dr. Chris Petell. The streptavidin-coated microarrays were loaded with biotinylated histone 
peptides that comprise exhaustive combinations of PTM marks, including H3K9me3. The GST-
tagged proteins were incubated with peptide microarrays overnight at 4 °C.  The concentrations of 
protein used for the arrays was the same for wild-type and the triple mutant. The arrays were 
probed with anti-GST antibodies. The arrays were washed and then probed with Alexa Fluor 647-
conjugated anti-rabbit antibody at 1:10,000 (ThermoFisher). Arrays were imaged using a Typhoon 
Scanner and protein binding was determined using ImageQuant array software (GE Healthcare). 




Results: Hypothesis 1 
 Reader proteins have been known to bind to PTMs on histone tails with higher specificity 
and less variability than previous antibody approaches10. We know that mutations previously 
identified in the beta-sheet region of HP1 reader protein have been found to increase binding 
affinity3, however, we did not know whether combinations of these single point mutations would 
be additive towards tighter binding. 
Experimental Design of Single Point Mutations: Verify Single Mutation binding affinities 
The first step of this project was to verify the results of previous work in order to then test 
the effects of the combinatorial mutagenesis. This was done because the previous method for 
measuring binding affinity was fluorescence anisotropy, however, we used ITC.  To do this, the 
single mutation DNA was first generated and then used as a template to create the combinations 
of mutations. The single mutants A25T, K46A, E52D, and D62F were generated using 
QuikChange PCR. In order to determine the success of the PCR reaction, the products were 
confirmed by gel electrophoresis before Dpn-1 digest and after the digest (Figure 2). The gel 
exhibited a band a 6 kb, which is the length of the pET-11a plasmid the mutations were 
introduced into. The plasmids were transformed into BL21-DE3 E. coli and the DNA was sent 
for Sanger sequencing (Genewiz) to verify the presence of the mutation.  
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Figure 2. Right: Gel electrophoresis of PCR plasmid before Dpn-1 digest, Left: Gel electrophoresis of 
plasmid after Dpn-1 digest. First lane is 1 kb DNA ladder. 
Binding Studies: A25T Weakens binding  
Once the presence of the mutations was confirmed, the single mutants binding affinity 
was measured by Isothermal Titration Calorimetry (ITC). ITC measures binding affinity by 
titrating the H3 histone tail peptide into the protein sample and measuring the change in heat as a 
result of binding. For the single mutations, ITC measurements were obtained by Mack Krone and 
Katherine Albanese (Figure 3). Binding affinities of single point mutations (K46A, E52D, D62F) 
were verified and shown to exhibit similar behaviors to previous work (Appendix I, Table 4). In 
contrast to the original findings, A25T, was shown to weaken binding affinity (Appendix I, 
DNA band at 6 
kb (pre-digest) 
 





Figure 3. Single mutants ITC binding curve (From Left to right: A25T, K46A, E52D, D62F). The binding 
affinities for K46A, E52D, D62F show similar increased binding affinities to previous work. A25T shows 
weakened binding affinity compared to previous results. 
 
Structural Characterization: Single mutations do not perturb structure 
The circular dichroism spectra were measured previously for each single mutation3 and this 
showed that the secondary structure was not perturbed by the mutations. Once the single mutations 
binding affinity was verified and was similar to the previous work, the binding affinities of the 
combinatorial mutations were than able to be obtained and compared to the single mutants.  
Experimental Design of Combinatorial Mutagenesis  
The combination of mutations was introduced using the single mutations as template DNA 
and using a different mutation primer to insert it into the plasmid. Out of the eleven combinatorial 
mutagenesis possibilities (Appendix I, Table 3), we were able to introduce all eleven mutations by 
the three PCR techniques, which include QuikChange PCR, gradient QuikChange PCR with 
annealing temperatures ranging from 65°C-85°C, and overlap PCR. The PCR reaction was verified 
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using gel electrophoresis as stated above. The presence of the mutations was then verified using 
Sanger sequencing.   
Binding Studies: Triple Mutation found to increase binding affinity to the nanomolar range 
First, the combinatorial mutations binding affinity was measured using ITC (Figure 4).  
Out of the double and triple mutants, the binding affinity improved the most for E52D/D62F, 
A25T/E52D/D62F, A25T/K46A/E52D/D62F, and lastly K46A/E52D/D62F (Appendix I, Table 
5). The goal was to find a mutant that reduced the Kd to nanomolar scale and the mutant that 
improved the binding affinity the most was K46A/E52D/D62F. The Kd value measured was 0.9 ± 
0.6 uM, which when compared to wild type, is a ~20 fold improvement in binding (Appendix I, 
Table 5). Initially we thought the quadruple mutant (A25T/K46A/E52D/D62F) would be the 
tightest binder if the mutations were additive. It was noted, however, that A25T actually weakened 




Figure 4. ITC binding curve of the WT HP1, triple mutant K46A/E52D/D62F, and quadruple mutant (from 
left to right). The triple mutant K46A/E52D/D62F has greatest binding affinity.  
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Structural Characterization: combinatorial mutations do not perturb structure 
The circular dichroism of the double and triple mutants was measured and this showed that the 
secondary structure was not perturbed by the double and triple mutations (Figure 5). The CD 
spectra show typical minima at 208 nm and 220 nm, which is indicative of alpha-helical structure. 
 
Figure 5. Circular dichroism of double and triple mutants compared to the wild type protein. The 
combinatorial mutations do not perturb the structure of the proteins. 
 
A thermal melting curve was also obtained by Mack Krone and Katherine Albanese in order to see 
if the mutations affected the stability of the protein, and global unfolding was measured by CD. 
The data showed that for the double and triple mutants that the proteins are stable at biological 
temperatures and denature close to where wild-type does at 47 degrees Celsius (Figure 6).  
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Figure 6. Thermal melting of double and triple mutants. The combinatorial mutations do not affect the 
folding of the proteins. 
 
Results: Hypothesis 2 
 Once the triple mutation (K46A/E52D/D62F) was determined to be the combination with 
the tightest binding affinity, we aimed to apply the super binder to biological assays to test the 
binding affinity and specificity. 
Peptide Pulldowns: Triple Mutant increases specificity and binding affinity 
The triple mutant protein was tagged with GST in order to be used in the peptide pulldown 
assays and the microarrays as a handle for the secondary anti-GST antibody. After GST 
purification, a protein gel was run of the GST-tagged wild-type protein and the triple mutant 
suggesting that translation was stalling at the GST-HP1 fusion site, so size exclusion 
chromatography was used to separate the truncated and full-length product (Figure 7). For the 
peptide pulldowns, the GST tagged wild-type HP1 protein and triple mutant protein were 
incubated with 4 different peptides including H3, H3K9me1, H3K9me2, H3K9me3. For the two 






















46/52 46/52/62 46/62 52/62 25/46/52/62
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than the wild-type (WT) protein at 10-fold lower concentration. Furthermore, at 500mM NaCl 
concentration, the enrichment for triple mutant bands was much greater than the wild-type protein 





Figure 7. Protein gel of GST-tagged Wild-type protein (Right four lanes) and Triple mutant GST-tagged 




Figure 8. Western blot of peptide pull-down at 300mM and 500mM NaCl concentrations for WT and the 
triple mutant protein (Top). Quantified enrichment data at 300mM and 500mM NaCl concentrations for WT 
and the triple mutant protein (Bottom). The triple mutant had a greater affinity for H3K9me3 compared to 
the wild-type protein. 
 
In order to test the selectivity of the triple mutant protein compared to WT, another pulldown 
experiment was conducted using H3K4me3, H3K9me3, and H3K27me3. The results showed that 
the triple mutant protein has greater selectivity for H3K9me3 compared to the wild-type protein 
(Figure 8). This was expected because for the triple mutant, by mutating the beta-sheet region we 
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were improving the cross-strand interactions with T6 of the histone tail. Other lysine sites that the 
triple mutant is selective over have a different recognition sequence, such as K27, which has an 
alanine in place of threonine at that position.   
 
Figure 9. Western blot of peptide-pulldown at 500mM NaCl with H3K4me3, H3k9me3, and H3K27me3 
peptides for WT and triple mutant. The triple mutant was more selective for H3K9me3 than other lysine site 
of H3. 
Microarrays: Triple mutant increases specificity and binding affinity compared to a wide range of 
histone tail sequences  
In order to further test the application of the triple mutant in biochemical assays, a 
microarray was used. Combinations of various histone tail sequences were tested.14 From this 
experiment, there were more hits for K9me, which includes all the methylation states of lysine 
(1/2/3) for the mutant protein than the wild-type protein (Figure 10). Furthermore, the mutant 
protein has increased signal intensity for K9me peptides than wild-type suggesting an increase in 
affinity for the mutant protein. This illustrates that the mutant protein has a higher affinity for 
K9me than other recognition sequences of histone tails.14 The mutant protein did also bind to 
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peptides other than K9me. This suggests that further testing would need to be done to test the 
specificity of our protein when in the presence of other peptide sequences.   
 
 
Figure 10. Microarray of WT protein (Left) and Triple mutant (right) with a wide range of peptides14. Picture 
comparing wild-type protein and the triple mutant protein. There is an increase in fluorescence for the triple 





The goal of this project was to determine if combinations of previously identified rational 
mutations would be additive and increase the binding affinity to the nanomolar range. The 
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mutation K46A/E52D/D62F of the HP1 chromodomain improves binding affinity by ~20 fold 
compared to the wild-type protein and has a Kd value in the nanomolar scale. This mutation can 
be a useful tool to improve the binding affinity of methyl lyisne reader proteins and could be a 
solution to the limitations of antibodies in recognizing PTMs.  
Furthermore, the A25T mutation actually weakens binding of the reader protein. This could 
contradict previous work3 because previously it had a 5,6-carboxyfluorescein (FAM) label, which 
is negatively charged. This could have improved binding interactions. The FAM label was 
included because in previous work the binding affinity of the mutations was measured with 
fluorescence anisotropy, which required a fluorescent signal. For this experiment, ITC was used 
and did not require the peptides to be FAM labeled. 
Hypothesis 2 
The second goal of this project was to apply a reader protein that binds in the nanomolar 
range to biochemical assays and see if the binding affinity and specificity could be improved. Once 
the triple mutation (K46A/E52D/D62F) was identified to be the tightest binder in the nanomolar 
range compared to the wild-type, the mutant was tagged with GST to determine the specificity of 
the triple mutant. First a peptide pulldown experiment was conducted with the different 
methylation states of lysine 9 for histone 3. It was found that the triple mutant HP1 has a higher 
specificity for H3K9me3 than the WT protein. A second peptide pulldown experiment was 
performed using histone 3 tails with different trimethyl lysine positions. It was found that 
compared to the wild-type protein that the triple mutant protein had a higher affinity for H3K9me3 
than other histone 3 trimethyllysines. Finally, a microarray was preformed that had a wide variety 
of different histone tails with common PTMs14 to test the binding ability of the triple mutant as 
well as the specificity. It was found that the triple mutant had more hits for H3K9me peptides than 
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the wild-type. It was also found that the fluorescence intensity for the triple mutant for H3K9me 
was stronger than when compared to wild-type. From the microarray, there were hits for peptides 
other than H3K9me and this may have been an effect of the GST tag. This was speculated because 
the GST tag is a homodimer and comes together in solution. This causes two HP1 proteins to be 
right next to each other and may be affecting the binding to H3K9me3. Not only was the GST tag 
most likely forming homodimers but it was also self-cleaving. This is seen on a protein gel taken 
before the peptide pulldowns and microarrays, and running a gel at a later timepoint indicated that 
degradation had continued (Figure 7).  
In order to determine if GST was interfering with the results, HP1 wild-type and triple 
mutant are currently being tagged with Maltose-Binding protein (MBP) in order to see if GST was 
affecting both the peptide pulldowns and the microarray. Preliminary MBP results have shown 
consistent trends with our GST-HP1 findings (Figure 11, Appendix I).  
After validating the HP1 super binder, further research would involve creating a series of 
super binders of other reader proteins. The first step in this process is to develop a mid-low nM 
super binder and we hope to continue our work to develop a reader protein that is a super binder 
and develop a library of detection reagents that can recognize any pattern of PTMs, which is a 
current antibody limitation.  
Further directions include introducing the triple point mutations (K46A/E52D/D62F) along 
with other mutations located in the aromatic cage of the HP1 protein. We would also like to 
crystallize our tightest binder to determine the structural source of the improvements.  
Another new direction the project is introducing the same three-point mutations into 
homologous mammalian genes (CBX). The mutated positions in HP1 are highly conserved 
residues among the mammalian homologs, so we hypothesize that the mutations would improve 
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binding affinities for the CBXs as well. In addition, another potential direction includes putting 
the mutant gene into stem cells or Drosophila and seeing how it effects the development of the 
cells or organism. Gene knockouts of reader proteins have been studied in fruit flies, but a reader 























Table 1. HP1 β-sheet Primer Design for QuikChange PCR 
Mutation Forward Primer Reverse Primer 
A25T GAG TAC ACC GTG GAA AAG 
ATC ATC GAC AGG  C   
 
GGT GTA CTC CTC CTC CTC 
CTC TTC GGC 
 
K46A GG GCG GGC TAT CCC GAA 
ACT GAG AAC ACG TGG  
 
GCC CGC  CCA  TTT  CAG  ATA  
GTA  CTC  CAC  CAT  TCC  C   
 
E52D CT GAC AAC ACG TGG GAG 
CCG GAG AAC  
 
GTT GTC 
AGT TTC GGG ATA GCC CTT 
CC   
 
 
D62F CTC TTC TGC CAG GAT CTT 
ATC CAG CAG TAC G  
 
GCA GAA GAG ATT GTT CTC 
CGG CTC CCA CGT G 
 
K46A_E52D GGG CGG GCT ATC CCG AAA 
CTG ACA ACA CGT GG 
 
Reverse of K46A 
 
Table 2. HP1 β-sheet Primer Design for Overlap PCR 
Mutation Forward Primer Reverse Primer 
OL Fwd CCGCTTCCACTTTTTCC n/a 











same as K46A 
 
 Table 3. Combinatorial mutagenesis of A25T, K46A, E52D, D62F. Compared to WT KD= 17µM 
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Protein Predicted Kd (µM) Predicted Fold  
Improvement 
25/46 0.85 20 
25/52 4.25 4 
25/62 2.83 6 
46/52 0.85 20 
46/62 0.57 30 
52/62 2.83 6 
25/46/52 0.43 40 
25/46/62 0.28 60 
25/52/62 1.42 12 
46/52/62 0.28 60 
25/46/52/62 0.14 120 
 
Table 4. Wild Type and single point mutations of HP1 ITC binding affinities.  





WT 14±2 - 
A25T 21±8 - 
K46A 4.5±0.5 3 
E52D 11±0.2 1.5 
D62F 4.1±0.3 3.5 
 
 
Table 5. Measured Kd value from ITC and fold improvement. 





25/46 - - 
25/52 18±2 - 
25/62 - - 
46/52 13.6 - 
46/62 4.7±0.6 4 
52/62 6.3±3.5 3 
25/46/52 8.4±1.3 2.5 
25/46/62 - - 
25/52/62 3.1 7 
46/52/62 0.7±0.2 20 
25/46/52/62 1.8±0.1 11 
 
Table 6. Thermal melting data of WT, single mutants, and combinatorial mutants.  
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